These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6133880)

  • 1. Reversed-phase high-performance liquid chromatography used to monitor enzymatic cleavage of pyrrolidone carboxylic acid from regulatory peptides.
    Dimaline R; Reeve JR
    J Chromatogr; 1983 Mar; 257(2):355-60. PubMed ID: 6133880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyroglutamic acid. Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal.
    Abraham GN; Podell DN
    Mol Cell Biochem; 1981 Aug; 38 Spec No(Pt 1):181-90. PubMed ID: 6117006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyroglutamyl N-termini of thermal polyamino acids.
    Melius P; Hubbard WL
    Biosystems; 1987; 20(3):213-7. PubMed ID: 2887217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of pyroglutamic acid in peptides.
    Suzuki Y; Motoi H; Sato K
    J Agric Food Chem; 1999 Aug; 47(8):3248-51. PubMed ID: 10552639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facile analysis and purification of deblocked N-terminal pyroglutamyl peptides with a strong cation-exchange sulfoethyl aspartamide column.
    Crimmins DL; McCourt DW; Schwartz BD
    Biochem Biophys Res Commun; 1988 Oct; 156(2):910-6. PubMed ID: 2903737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay of pyroglutamyl aminopeptidase by high-performance liquid chromatography and its use in peptide sequencing.
    Martini F; Bossa F; Barra D
    Peptides; 1985; 6 Suppl 3():103-5. PubMed ID: 2870471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrolytic cleavage of pyroglutamyl-peptide bond. I. The susceptibility of pyroglutamyl-peptide bond to dilute hydrochloric acid.
    Hashimoto T; Ohki K; Sakura N
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2068-74. PubMed ID: 8582011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weak acid-catalyzed pyrrolidone carboxylic acid formation from glutamine during solid phase peptide synthesis. Minimization by rapid coupling.
    Dimarchi RD; Tam JP; Kent SB; Merrifield RB
    Int J Pept Protein Res; 1982 Jan; 19(1):88-93. PubMed ID: 7118385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatography with fluorimetric detection in biological tissues of the 4-bromomethyl-7-methoxycoumarin ester derivative of 5-pyrrolidone-2-carboxylic acid.
    Bousquet E; Romeo G; Giannola LI
    J Chromatogr; 1985 Nov; 344():325-31. PubMed ID: 4086554
    [No Abstract]   [Full Text] [Related]  

  • 10. Pyrrolidone carboxylic acid synthesis in guinea pig epidermis.
    Barrett JG; Scott IR
    J Invest Dermatol; 1983 Aug; 81(2):122-4. PubMed ID: 6135734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and identification of indigestible pyroglutamyl peptides in an enzymatic hydrolysate of wheat gluten prepared on an industrial scale.
    Higaki-Sato N; Sato K; Esumi Y; Okumura T; Yoshikawa H; Tanaka-Kuwajima C; Kurata A; Kotaru M; Kawabata M; Nakamura Y; Ohtsuki K
    J Agric Food Chem; 2003 Jan; 51(1):8-13. PubMed ID: 12502378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of 5-pyrrolidone-2-carboxylate ester by reverse phase high-performance liquid chromatography.
    Bousquet E; Guarcello V; Morale MC; Rizza V
    Anal Biochem; 1983 May; 131(1):135-40. PubMed ID: 6614444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of N-terminal formyl groups and deblocking of pyrrolidone carboxylic acid of proteins with anhydrous hydrazine vapor.
    Miyatake N; Kamo M; Satake K; Uchiyama Y; Tsugita A
    Eur J Biochem; 1993 Mar; 212(3):785-9. PubMed ID: 8462549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique amino terminal structure of rat little gastrin.
    Reeve JR; Dimaline R; Shively JE; Hawke D; Chew P; Walsh JH
    Peptides; 1981; 2(4):453-8. PubMed ID: 7329823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of N-terminal blocking groups from proteins.
    Leone JW; Hampton B; Fowler E; Moyer M; Krishna RG; Chin CCQ
    Curr Protoc Protein Sci; 2011 Feb; Chapter 11():11.7.1-11.7.20. PubMed ID: 21400688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prodrugs of peptides. 19. Protection of the pyroglutamyl residue against pyroglutamyl aminopeptidase by N-acyloxymethylation and other means.
    Møss J; Bundgaard H
    Acta Pharm Nord; 1992; 4(4):301-8. PubMed ID: 1363462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of a series of residue 1 (pyroglutamic acid) analogs of thyrotrophin releasing hormone.
    Bauce LG; Goren HJ
    Int J Pept Protein Res; 1979; 14(3):216-26. PubMed ID: 118133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyroglutamyl diazomethyl ketone: potent inhibitor of mammalian pyroglutamyl peptide hydrolase.
    Wilk S; Friedman TC; Kline TB
    Biochem Biophys Res Commun; 1985 Jul; 130(2):662-8. PubMed ID: 2862865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methanolysis of the pyrrolidone ring of amino-terminal pyroglutamic acid in model peptides.
    Kawasaki I; Itano HA
    Anal Biochem; 1972 Aug; 48(2):546-56. PubMed ID: 4115984
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo kinetics of pyrrolidonecarboxylic acid formation in selected silkmoth chorion proteins.
    Regier JC; Kafatos FC
    J Biol Chem; 1981 Jun; 256(12):6444-51. PubMed ID: 7240217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.